Patents by Inventor Roland Heinig

Roland Heinig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG FORMULATIONS HAVING IMPROVED PHARMACOKINETIC PROPERTIES
    Publication number: 20140186444
    Abstract: The present application relates to novel drug formulations of vardenafil which dissolve rapidly in the mouth and lead to increased bioavailability and to a plateau-like plasma concentration profile, and to processes for their preparation.
    Type: Application
    Filed: December 16, 2013
    Publication date: July 3, 2014
    Inventors: Peter Serno, Roland Heinig, Kerstin Pauli, Yutaka Hayauchi
  • Pharmaceutical forms with improved pharmacokinetic properties
    Patent number: 8613950
    Abstract: The present application relates to novel drug formulations of vardenafil which dissolve rapidly in the mouth and lead to increased bioavailability and to a plateau-like plasma concentration profile, and to processes for their preparation.
    Type: Grant
    Filed: February 16, 2006
    Date of Patent: December 24, 2013
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Peter Serno, Roland Heinig, Kerstin Pauli, Yutaka Hayauchi
  • Drug Forms Having Controlled Bioavailability
    Publication number: 20090017122
    Abstract: The present application relates to novel drug formulations of vardenafil which dissolve rapidly in the mouth and have controlled bioavailability, and to processes for their preparation.
    Type: Application
    Filed: February 22, 2006
    Publication date: January 15, 2009
    Applicant: Bayer HealthCare AG
    Inventors: Peter Serno, Roland Heinig, Kerstin Pauli
  • Formulations with Controlled Release of Active Ingredient
    Publication number: 20080268046
    Abstract: The present invention relates to novel pharmaceutical dosage forms with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphic forms thereof as active ingredient, and to the production thereof. The invention further relates to the use of these novel pharmaceutical dosage forms as medicaments, and to their use for producing medicaments for the treatment and/or prevention of disorders in humans and animals.
    Type: Application
    Filed: April 29, 2005
    Publication date: October 30, 2008
    Applicant: BAYER HEALTHCARE AG
    Inventors: Susanne Zuleger, Peter Serno, Helmut Haning, Kerstin Pauli, Roland Heinig
  • Pharmaceutical Forms with Improved Pharmacokinetic Properties
    Publication number: 20080249096
    Abstract: The present application relates to novel drug formulations of vardenafil which dissolve rapidly in the mouth and lead to increased bioavailability and to a plateau-like plasma concentration profile, and to processes for their preparation.
    Type: Application
    Filed: February 16, 2006
    Publication date: October 9, 2008
    Applicant: BAYER HEALTHCARE AG
    Inventors: Peter Serno, Roland Heinig, Kerstin Pauli, Yutaka Hayauchi
  • Formulations With Controlled Release Of Active Ingredient
    Publication number: 20080187588
    Abstract: The present invention relates to novel pharmaceutical dosage forms with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphic forms thereof as active ingredient, and to the production thereof. The invention further relates to the use of these novel pharmaceutical dosage forms as medicaments, and to their use for producing medicaments for the treatment and/or prevention of disorders in humans and animals.
    Type: Application
    Filed: May 10, 2005
    Publication date: August 7, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Susanne Zuleger, Peter Serno, Helmut Haning, Kerstin Pauli, Roland Heinig